Page last updated: 2024-08-18

scoparone and Prostatic Neoplasms

scoparone has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, WJ; Harris, RA; Kim, HJ; Kim, JK; Kim, JY; Lee, IK; Lee, JT; Park, KG1

Other Studies

1 other study(ies) available for scoparone and Prostatic Neoplasms

ArticleYear
Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Antineoplastic Agents; Artemisia; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Coumarins; Cyclin D1; G1 Phase; HCT116 Cells; HeLa Cells; Hep G2 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Interleukin-6; Janus Kinase 2; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Survivin; Transcription, Genetic

2013